|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1994-6-30
|
|
pubmed:abstractText |
To clarify the relationship between changes in haemodynamics, liberation of tumour necrosis factor and generation of plasma kallikrein, and to see if treatment with a combination of drugs was successful in preventing activation of tumour necrosis factor and plasma kallikrein in experimental endotoxic shock.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1102-4151
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
160
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
77-86
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8193212-Animals,
pubmed-meshheading:8193212-Disease Models, Animal,
pubmed-meshheading:8193212-Drug Therapy, Combination,
pubmed-meshheading:8193212-Escherichia coli Infections,
pubmed-meshheading:8193212-Hemodynamics,
pubmed-meshheading:8193212-Kallikreins,
pubmed-meshheading:8193212-Ketanserin,
pubmed-meshheading:8193212-Methylprednisolone,
pubmed-meshheading:8193212-Naloxone,
pubmed-meshheading:8193212-Promethazine,
pubmed-meshheading:8193212-Protease Inhibitors,
pubmed-meshheading:8193212-Shock, Septic,
pubmed-meshheading:8193212-Swine,
pubmed-meshheading:8193212-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Effects of a combined drug regimen on tumour necrosis factor and plasma kallikrein activity in experimental endotoxaemia.
|
|
pubmed:affiliation |
Department of Surgery, Ullevål Hospital, University of Oslo, Norway.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
